Displaying drugs 6451 - 6475 of 8035 in total
Firategrast
Firategrast has been used in trials studying the treatment of Multiple Sclerosis.
Investigational
Matched Description: … Firategrast has been used in trials studying the treatment of Multiple Sclerosis. …
Tiplimotide
Tiplimotide has been used in trials studying the treatment of Multiple Sclerosis.
Investigational
Matched Description: … Tiplimotide has been used in trials studying the treatment of Multiple Sclerosis. …
GW-493838
GW493838 has been used in trials studying the treatment of Neuropathic Pain.
Investigational
Matched Description: … GW493838 has been used in trials studying the treatment of Neuropathic Pain. …
Hydroxytyrosol
Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Description: … Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer. …
E-6005
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
Matched Description: … E6005 has been used in trials studying the treatment of Atopic Dermatitis. …
SCH-486757
Sch 486757 has been used in trials studying the treatment of Cough.
Investigational
Matched Description: … Sch 486757 has been used in trials studying the treatment of Cough. …
p-Quaterphenyl
p-Quaterphenyl has been used in trials studying the treatment of Malaria.
Investigational
Matched Description: … p-Quaterphenyl has been used in trials studying the treatment of Malaria. …
Laniquidar
Laniquidar has been used in trials studying the treatment of Breast Cancer.
Investigational
Matched Description: … Laniquidar has been used in trials studying the treatment of Breast Cancer. …
PF-04217903
PF-04217903 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
Clazakizumab
Clazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Clazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
Timonacic
Timonacic has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Timonacic has been used in trials studying the treatment of HIV Infections. …
Raluridine
Raluridine has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Raluridine has been used in trials studying the treatment of HIV Infections. …
Roniciclib
Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma.
Investigational
Matched Description: … Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma. …
Cibinetide
Cibinetide has been used in trials studying the basic science of Depression.
Investigational
Matched Description: … Cibinetide has been used in trials studying the basic science of Depression. …
Hypericin
Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma.
Investigational
Matched Description: … Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma. …
LY-2874455
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
Investigational
Matched Description: … LY2874455 has been used in trials studying the treatment of Advanced Cancer. …
Tucaresol
Tucaresol has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Tucaresol has been used in trials studying the treatment of HIV Infections. …
Biapenem
Biapenem has been used in trials studying the treatment of Bacterial Infections.
Investigational
Matched Description: … Biapenem has been used in trials studying the treatment of Bacterial Infections. …
Methanesulfonyl Fluoride
Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.
Investigational
Matched Description: … Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety. …
Nefiracetam
Nefiracetam has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Nefiracetam has been used in trials studying the treatment of Alzheimer's Disease. …
Ketodarolutamide
Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of darolutamide.
Experimental
Matched Description: … Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of [darolutamide …
GSBR-1290
GSBR-1290 is a small molecule agonist of the GLP-1 receptor.
Investigational
Matched Description: … GSBR-1290 is a small molecule agonist of the GLP-1 receptor. …
Ciglitazone
Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class.
Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones. Several analogues were later developed, some of which—such as pioglitazone and troglitazone—made it to the market....
Experimental
Matched Description: … Ciglitazone is a potent and selective PPARγ ligand with an EC50 of 3.0 µM. ... Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones ... Several analogues were later developed, some of which—such as pioglitazone and troglitazone—made it to …
MYR-101
MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy intended to treat Canavan disease. Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the brain. It is caused by a mutation in the aspartoacylase gene (ASPA), which leads to a deficiency of the...
Investigational
Matched Description: … ASPA is produced in oligodendrocytes, and participates in the metabolism of N-acetylaspartate (NAA). ... granted MYR-101 Fast Track, Rare Pediatric Disease (RPD), and Orphan Drug designations for the treatment of ... It is caused by a mutation in the aspartoacylase gene (_ASPA_), which leads to a deficiency of the aspartoacylase …
CZEN 002
CZEN-002 is a novel, non-azole anti-fungal synthetic octapeptide, derived from alpha-Melanocyte-Stimulating Hormone (a-MSH). CZEN-002 modulates inflammatory and immune responses. It has also been shown to kill Candida albicans (C. albicans), a single-celled fungal organism that causes a variety of infections, including vaginitis. This organism can invade tissues and produce fatal...
Investigational
Matched Description: … Studies attempting to understand the candidacidal activity of derivatives of alpha-MSH have focused on ... shown to kill Candida albicans (C. albicans), a single-celled fungal organism that causes a variety of ... The antimicrobial activity of CZEN-002 is unique in that it does not depend on direct damage to the microbial …
Displaying drugs 6451 - 6475 of 8035 in total